SFDA Warns Against Using the Batch Number (MC1605) of "Biotrue Multi-Purpose Solution" as it is Possible to Lead to Conjunctivitis
2019-01-20
Drugs
Drugs
Other News
SFDA Captured Violations in 108 Pharmaceutical Products Warehouses
2016-11-07
SFDA Captured Violations in 108 Pharmaceutical Products Warehouses in three months.
SFDA announced that its specialists conducted periodical inspection tours to the warehouses of drug importers and promotes, in line with SFDA efforts in tracing pharmaceutical products marked in the Kingdom to insure their safety, quality and efficacy and compliance to storage and distribution conditions approved by SFDA.
Other News
SFDA captured 1411 violating products in “Attarah stores “in Riyadh
2016-05-17
SFDA inspectors detected 1411 violating products in a number of Attarat’s stores during thier inspection tours. In a statement SFDA cleared that it’s inspection teams checked a number of Attarat’s stores in Riyadh as part of their inspection program of pharmaceutical products that have medical claims illegally traded in the local market where they captured 1411 violated products.
Other News
SFDA Hosts Middle East Regulatory Conference for Drug Legislations
2015-12-01
SFDA will host tomorrow (Tuesday) at the Riyadh Marriot Hotel “The 11th. Middle East Regulatory Conference (MERC) for drug legislations” under the auspice of H.E. SFDA CEO, DR. Mohamed bin Abdul Rahman Almishal in coordination sith Drug Information Association (DIA).
Other News
SFDA Forces Cosmetics Factories & Importers to gradually register their products electronically
2015-05-05
Other News
SFDA VP: Drug Clearance will be given to authorized agents and licensed stores only
2015-05-05
The Vice President of SFDA Drug Sector, Dr. Ibrahim Al Jufali, confirmed that SFDA strategy adopts the best international practices of control to face drug fraud.
Al Jufali said,’ SFDA saves no effort in countering drug fraud through establishing the necessary laws and regulations to prevent the entry of fake drugs and put the necessary plans and mechanisms in place to strengthen control on the supply chain and to prevent trading or marketing of fake or violating drugs.
Other News
Risk of hypersensitivity reactions of products containing ambroxol and bromhexine
2014-07-07
The Saudi Food and Drug Authority would like to inform the healthcare professionals and the public that after reviewing the safety profile for products containing ambroxol and bromhexine (secretolytic agents of acute and chronic bronchopulmonary diseases), it has been found that these drugs might be associated with rare but severe allergic reactions such as anaphylactic shock.
Other News
Drug Sector Welcomes Al Majma’ah University Students
2013-02-26
SFDA welcomed at its Head Office a student delegation from the faculty of Medicine & Pharmacology of Al Majma’ah University, on Tuesday 2/4/1434H.
Other News
Saudi Food and Drug Authority (SFDA) PRESS RELEASE- Safety of Diane 35® and Risk of Thromboembolism
2013-02-11
The Saudi Food and Drug Authority (SFDA) would like to share some recent information regarding use of Diane 35® (cyproterone acetate 2 mg + ethinyl estradiol 35 micrograms). On 30/01/2013, the French medicines agency (ANSM) announced that they decided to suspend the marketing authorisation for Diane 35® and its generics for acne treatment in France within three months. This decision was based on review of known data by the French medicines agency.
Other News
Measures to minimise the risk of developing nephrogenic systemic fibrosis with the use of gadolinium-containing contrast agents
2013-02-10
The European Committee for Medicinal Products for Human Use (CHMP) has
reviewed the risk of nephrogenic systemic fibrosis (NSF) with gadolinium containing
contrast agents.
On the basis of current evidence, the risk classification is as follows:
High risk—Omniscan (gadodiamide), OptiMARK (gadoversetamide),Magnevist (gadopentetic acid)
Medium risk—MultiHance (gadobenic acid), Primovist (gadoxetic acid),
Vasovist (gadofosveset)